
    
      The EFEMORAL I study is a prospective, single-arm, open-labeled, multi-center, clinical
      investigation enrolling patients with arterial diameter of ≥5.5 mm and ≤6.5 mm and lesion
      length ≤90 mm receiving a single EVSS.
    
  